Table 2.
Polymorphisms | Patients | Controls | OR (95% CI) | P |
---|---|---|---|---|
n = 179 (%) | n = 237 (%) | |||
rs1501299 | ||||
genotypes | ||||
AA | 10(5.6) | 16(6.8) | 1.00 (Ref) | |
AC | 85(47.5) | 92(38.8) | 0.68(0.29–1.57) | .362 |
CC | 84(46.9) | 129(54.4) | 0.96(0.42–2.22) | .923 |
alleles | ||||
A | 105(29.3) | 124(26.2) | 1.00 (Ref) | |
C | 253(70.7) | 350(73.8) | 1.17(0.86–1.59) | .311 |
rs2241766 | ||||
genotypes | ||||
GG | 15(8.4) | 19(8.0) | 1.00 (Ref) | |
GT | 83(46.4) | 113(47.7) | 1.08(0.52–2.24) | .847 |
TT | 81(45.3) | 105(44.3) | 1.023(0.49–2.14) | .951 |
alleles | ||||
G | 113(31.6) | 151(31.9) | 1.00 (Ref) | |
T | 245(68.4) | 323(68.1) | 0.99(0.74–1.33) | .929 |
For rs1501299, the AA genotype and A allele were used as reference [1.00 (ref)]; for rs2241766, the GG genotype and G were used as reference [1.00 (ref)].